ArticleOncology letters2023
Death within 9 months in patient with follicular dendritic cell sarcoma of spleen: A case report.
Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular dendritic cells are derived from the stroma. They are present in the germinal centers of lymph nodes and involved in antigen presentation, proliferation and differentiation of B cells. Follicular dendritic cell sarcoma (FDCS) is a relatively rare malignant tumor and its biological behavior is usually indolent. Most patients may be cured by complete surgical resection. Local recurrence may be present in >40% of cases and ~25% of cases may have metastasis. Recurrence or metastasis may not occur until numerous years later. In previous case reports, patients with splenic FDCS recovered or were stable after surgical resection of the tumor. In the present case, the tumor was initially located at the lower end of the spleen and radical resection was performed by laparoscopy without lymph node and distant organ metastasis. However, multiple metastases occurred after surgical resection. The patient received chemotherapy and radiotherapy, but his condition did not improve. The time from discovery of spleen tumor to death of the patient was 9 months. The purpose of the present case report was to raise clinicians' awareness of the disease, provide information about the treatment process and incite research on splenic FDCS and its prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.